British Biotech

6 days ago

You can be bearish of Avacta without batting for cancer, hoping cancer wins

Folks can get understandably emotional about cancer. I remember chatting almost thirty years ago to a cousin of my mother whose wife had, sadly, died at all too young an age from breast cancer. The chap said that in her memory he had bought a large number of shares in British Biotech, a company that at one stage was bigger than Railtrack, a unicorn.

578 days ago

Now really is a good time to short Avacta, its shareholder base is terribly naive

I started writing about biotech and emerging pharma stocks more than 30 years ago when I was at the Investors Chronicle. The army of PI cheerleaders for Avacta (AVCT) probably have not heard of British Biotech, a £2 billion blow up, of ML Labs a half a billion blow up. Almost thirty years ago I exposed both companies for the overvalued crocks they were and also for the way that they duped investors with misleading releases